1![A Novel Descriptor Based on Atom-Pair Properties Masataka Kuroda Mitsubishi Tanabe Pharma Corporation Descriptors can be classified into several groups. Property and fingerprint belong to zero and one dimensional descri A Novel Descriptor Based on Atom-Pair Properties Masataka Kuroda Mitsubishi Tanabe Pharma Corporation Descriptors can be classified into several groups. Property and fingerprint belong to zero and one dimensional descri](https://www.pdfsearch.io/img/f8bd37e621c3e9b533b7c927a52bcaac.jpg) | Add to Reading ListSource URL: cisrg.shef.ac.uk- Date: 2016-07-14 11:08:40
|
---|
2![Contribution to Academic Study and Research for the Future Index Contribution to Academic Study and Research for the Future Index](https://www.pdfsearch.io/img/12b2dacc9b8509f0f08bbd45c2d163c8.jpg) | Add to Reading ListSource URL: www.mitsubishi.comLanguage: English - Date: 2016-02-29 23:34:13
|
---|
3![EXHIBITION FREE OF CHARGE: 1. Enjoy our free voice guide machine! (English, Chinese, Korean and Japanese) EXHIBITION FREE OF CHARGE: 1. Enjoy our free voice guide machine! (English, Chinese, Korean and Japanese)](https://www.pdfsearch.io/img/02404b051ae313cb45ea951727a6569f.jpg) | Add to Reading ListSource URL: www.kigyoka.jpLanguage: English - Date: 2015-12-01 01:13:50
|
---|
4![April 4, 2016 Press Release Mitsubishi Tanabe Pharma Corporation MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore April 4, 2016 Press Release Mitsubishi Tanabe Pharma Corporation MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore](https://www.pdfsearch.io/img/a0e668c7fb3f3f3bcea55556b22b813c.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English |
---|
5![December 21, 2015 Press release Mitsubishi Tanabe Pharma Corporation Remicade® for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease December 21, 2015 Press release Mitsubishi Tanabe Pharma Corporation Remicade® for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease](https://www.pdfsearch.io/img/cdd6f0b1c23dc463b754175031b60086.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2015-12-21 01:49:29
|
---|
6![Announcement of an approval for an additional indication for the Anti-depressant, Lexapro® Tablets10 mg in Japan Mochida Pharmaceutical Co., Ltd. Mitsubishi Tanabe Pharma Corporation (Tokyo, November 20, 2015) We, Mochi Announcement of an approval for an additional indication for the Anti-depressant, Lexapro® Tablets10 mg in Japan Mochida Pharmaceutical Co., Ltd. Mitsubishi Tanabe Pharma Corporation (Tokyo, November 20, 2015) We, Mochi](https://www.pdfsearch.io/img/3ed10c99de24a230b18845229397f348.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2015-11-19 22:53:25
|
---|
7![November 30, 2015 Press release Company name: Mitsubishi Tanabe Pharma Corporation Representative: Masayuki Mitsuka President and Representative Director Code number: November 30, 2015 Press release Company name: Mitsubishi Tanabe Pharma Corporation Representative: Masayuki Mitsuka President and Representative Director Code number:](https://www.pdfsearch.io/img/1f6f0fbb0a0eaa74b0ee54fe0176cac1.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2015-11-29 02:42:58
|
---|
8![March 22, 2016 Press release Mitsubishi Tanabe Pharma Corporation Valixa® Tablet 450 mg Application for Additional Indication in Japan for the Prevention of March 22, 2016 Press release Mitsubishi Tanabe Pharma Corporation Valixa® Tablet 450 mg Application for Additional Indication in Japan for the Prevention of](https://www.pdfsearch.io/img/321e6f9c490c0b0d42b7bdddc7f6e3c6.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2016-03-22 00:05:33
|
---|
9![March 10, 2016 Press release Mitsubishi Tanabe Pharma Corporation Notice regarding change of current commercialization scheme to new strategic co-promotion partnership in Japan for RA treatment agent March 10, 2016 Press release Mitsubishi Tanabe Pharma Corporation Notice regarding change of current commercialization scheme to new strategic co-promotion partnership in Japan for RA treatment agent](https://www.pdfsearch.io/img/6c58ec6a3b5ccbc946c5483cee9c5ee3.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2016-03-09 20:19:14
|
---|
10![October 30, 2015 Press release Mitsubishi Tanabe Pharma Corporation Medicago Engaged by the Canadian Government Produce Ebola Monoclonal Antibodies October 30, 2015 Press release Mitsubishi Tanabe Pharma Corporation Medicago Engaged by the Canadian Government Produce Ebola Monoclonal Antibodies](https://www.pdfsearch.io/img/35973b2268d2605d3948b0a1f55243df.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2015-10-29 06:36:36
|
---|